Meridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward
Go back to Meridian Bioscience Reports First Quarter 2017 Operating Results, Reduces Regular Cash Dividend, and Revises Fiscal 2017 Guidance Downward| Meridian Bioscience, Inc. (NASDAQ: VIVO) | Delayed: 5.87 +0.42 (7.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.45 | 52 Week High | $21.49 | |||
| Open | $5.51 | 52 Week Low | $15.75 | |||
| Day High | $6.24 | P/E | 6.67 | |||
| Day Low | $5.35 | EPS | $0.88 | |||
| Volume | 1,863,790 | |||||
